Clinical Perspectives on Long‐Term Albumin Therapy in Decompensated Cirrhosis: A Nationwide Delphi Survey in Spain—The <scp>ALBA</scp> Study
Panellists considered long-term albumin administration to be clinically beneficial and prioritised its use for patients with advanced-stage disease, regardless of transplant candidacy. However, integration into routine practice remains limited due to a lack of robust supporting evidence, along with institutional and logistical barriers. A national registry and targeted strategies to optimise use and resource allocation were endorsed.
Authors
- Rafael Bañares (ORCID: https://orcid.org/0000-0002-0412-8437)
- Elsa Solá Vergés
- José Ignacio Fortea (ORCID: https://orcid.org/0000-0001-5255-9445)
- Agustı́n Albillos (ORCID: https://orcid.org/0000-0001-9131-2592)
- Diego Rincón (ORCID: https://orcid.org/0000-0002-4470-7724)
Institutions
- Universidad Complutense de Madrid (ES)
- Universidad de Alcalá (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Marqués de Valdecilla University Hospital (ES)
- Instituto de Investigación Marqués de Valdecilla (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
- Stanford Medicine (US)
- Hospital Universitario Ramón y Cajal (ES)
- Stanford University (US)
Publication Details
- Journal
- Liver International
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1111/liv.70429
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Asociación Española para el Estudio del Hígado
- Grifols
- Instituto de Salud Carlos III
- European Regional Development Fund